Organic Active Ingredients TRIZ Cases

Engineered anti-bacterial drones deliver antibacterial cargo into bacterial cells, bypassing antibiotic resistance mechanisms.

Sugar inhibits collagen gelation in vitro to improve handleability, then allows in vivo gelation for sustained drug release.

Chick chorioallantoic membrane assay detects vascular activity to identify thyroid hormone-driven resistance before treatment.

Formula I pyrimidines overcome T790M drug resistance by modifying chemical structure to selectively bind the mutant binding pocket.

Segmented drug depot concentrates clonidine at surgical sites to reduce systemic side effects while sustaining analgesia.

This multi-route nutrient delivery system segments dosage across enteral, parenteral, and topical pathways to prevent toxicity while achieving permanent aesthetic enhancements.

Pyrazine derivatives disrupt viral nucleocapsid formation to overcome drug resistance and adverse events associated with existing hepatitis B treatments.

Antisense oligonucleotides target TNFR2 mRNA to resolve specificity limitations in therapeutic modulation.

Continuous extrusion replaces batch pressing to increase volume throughput and reduce labor intensity while maintaining cannabinoid potency.

Introducing a biocompatible composition prevents fibrous septae regrowth after mechanical disruption, eliminating the need for repeat subcision procedures.

Formylated N-heterocyclic derivatives inhibit FGFR4 receptors to treat liver cancer and glioblastoma while resolving therapeutic effectiveness trade-offs.

A green tea extract composition containing specific GCG and EGCG levels treats female hormone regulation disorders.

Replacing the 1,3-dicarbonyl moiety with a pyrazole ring enhances brain penetration and potency for Alzheimer's treatment.

Fructosamine-3-kinase breaks down advanced glycation end products to reduce drusen density and restore light transmission.

Synthetic deoxycholic acid compositions eliminate animal pathogen risks while enabling localized fat removal via amphiphilic solubilization of adipocytes.

Segmenting antisense therapy into two linked oligonucleotides eliminates off-target effects by requiring precise dual-site binding.

A BAFF Trap fusion protein combines TACI and Br3 receptor domains with an IgG1 Fc fragment to create a potent antagonist.

Lambda-carrageenan compositions inhibit viral transmission on epithelial tissues while stabilizing viscosity and preventing sticky residues.

Selective gamma-secretase inhibitors reduce neurotoxic beta-amyloid 42 production while preserving shorter peptide forms.

Extruding gum base through a die into liquid creates smooth particles, reducing labor costs and improving cannabinoid release profiles.

Site-directed coupling of humanized antibodies to cytotoxic drugs enhances binding affinity and tumor inhibition rates.

Organic acid maintains drug solubility in the adhesive matrix, preventing crystal precipitation while enhancing skin permeability for osteoarthritis treatment.

Administering glucocorticoid receptor antagonists alongside androgen receptor degraders degrades resistant protein variants to restore treatment sensitivity.

Aromatic-cationic peptides penetrate cell membranes to treat dominant optic atrophy, addressing limited success of existing therapeutic options.

Aldehyde-modified hyaluronic acid conjugates with protein N-termini to enable transdermal delivery, bypassing complex device requirements for skin permeability.

Circular single-chain RNA structure resists enzymatic degradation through loop-mediated ligation, maintaining 70% serum retention after eight hours.

Novel thiazole derivatives inhibit host cell nucleic acid synthesis to block viral replication.

Hycanthone and Primaquine derivatives induce apoptosis in gammaherpesvirus-infected cells.

A vaporization delivery method using glycol solvent transports herbal medicine active agents to the lungs.

Inhaled ALK5 inhibitor formulations deliver therapeutic compounds directly to lung tissue via aerosol or dry powder routes.

Inclusion complexes mask bitter taste and numbing sensations while maintaining therapeutic bioavailability.

Naphthyridine-substituted pyridazine compounds bind to the allosteric site of the muscarinic acetylcholine receptor M4 to enhance activity.

Nanoparticle delivery of Hedgehog pathway inhibitors eliminates resistant cancer stem cells while minimizing systemic toxicity.

Segmenting the tablet into a disintegrant core and a protective coating layer resolves the contradiction between rapid disintegration and photostability.

Synthetic multiantennary glycolipids resolve manufacturing precision issues by establishing stereoselective linkages to prevent cytokine storms.

Oral aryl inhibitors block Factor D upstream, resolving anemia from incomplete C5 suppression.

Bioorthogonal click chemistry crosslinks embolic hydrogels in vivo, delivering complete vessel occlusion for complex vascular malformations.

Adjusting buffer pH to 7.4–7.8 enables hydroxypropyl β-cyclodextrin inclusion compounds, overcoming low naringenin solubility for aerosol delivery.

Standardized Chrysanthemum zawadskii extract resolves inconsistent component levels by applying parameter changes to temperature and time.

Combining chimeric VEGF Trap with irinotecan achieves therapeutic synergism that reduces toxic side effects while maintaining antitumor activity at lower doses.

Replacing microcrystalline cellulose with glyceryl monostearate and polymeric binders prevents moisture-catalyzed degradation of sensitive active ingredients.

Carbazole derivatives provide selective binding to the 5-HT6 receptor through targeted molecular modifications.